WANBURY
Back to All Ratios
|
WANBURY Last 5 Year EV/Core EBITDA History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
EV/Core EBITDA(x) | 7.97 | 7.57 | 8.67 | 17.44 | 7.83 |
What is the latest EV/Core EBITDA ratio of WANBURY ?
Year | EV/Core EBITDA |
---|---|
Mar2024 | 7.97 |
Mar2023 | 7.57 |
Mar2022 | 8.67 |
Mar2021 | 17.44 |
Mar2020 | 7.83 |
How is EV/Core EBITDA of WANBURY Trending?
Years | EV/Core EBITDA | % Change | |
---|---|---|---|
Mar2024 | 7.97 | 5.28 | |
Mar2023 | 7.57 | -12.69 | |
Mar2022 | 8.67 | -50.29 | |
Mar2021 | 17.44 | 122.73 | |
Mar2020 | 7.83 | - |
Other Financial Ratios of WANBURY
Operational & Financial Ratios Earnings Per Share CEPS DPS Book NAV/Share Tax Rate | Margin Ratios Core EBITDA Margin EBIT Margin Pre Tax Margin PAT Margin Cash Profit Margin | Performance Ratios ROA ROE ROCE Asset Turnover Sales/Fixed Asset Working Capital/Sales | Efficiency Ratios Fixed Capital/Sales Receivable days Inventory Days Payable days | Valuation Parameters PER PCE Price/Book Yield EV/Net Sales EV/EBIT EV/CE M Cap / Sales | Growth Ratios Net Sales Growth Core EBITDA Growth EBIT Growth PAT Growth EPS Growth | Financial Stability Ratios Total Debt/Equity Current Ratio Quick Ratio Interest Cover Total Debt/Mcap |
Compare EV/Core EBITDA ratio of peers of WANBURY
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
WANBURY | ₹862.0 Cr | 11.4% | 25% | 69.5% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹420,136.0 Cr | 6% | 4% | 9.9% | Stock Analytics | |
DIVIS LABORATORIES | ₹149,680.0 Cr | 4.7% | 0.3% | 52.4% | Stock Analytics | |
CIPLA | ₹122,394.0 Cr | 7% | 3.7% | 7.2% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹110,159.0 Cr | 4.1% | 6.4% | 25% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹97,105.6 Cr | 6.3% | 5% | -4.7% | Stock Analytics |
WANBURY Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
WANBURY | 11.4% |
25% |
69.5% |
SENSEX | 5.8% |
6.1% |
4.7% |
You may also like the below Video Courses